JP2023515665A5 - - Google Patents
Info
- Publication number
- JP2023515665A5 JP2023515665A5 JP2022552541A JP2022552541A JP2023515665A5 JP 2023515665 A5 JP2023515665 A5 JP 2023515665A5 JP 2022552541 A JP2022552541 A JP 2022552541A JP 2022552541 A JP2022552541 A JP 2022552541A JP 2023515665 A5 JP2023515665 A5 JP 2023515665A5
- Authority
- JP
- Japan
- Prior art keywords
- snps
- snp
- assayed
- reagent
- specific portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062986603P | 2020-03-06 | 2020-03-06 | |
| US62/986,603 | 2020-03-06 | ||
| PCT/US2021/019265 WO2021178166A1 (en) | 2020-03-06 | 2021-02-23 | Compositions and methods for assessing the efficacy of inhibitors of neurotransmitter transporters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515665A JP2023515665A (ja) | 2023-04-13 |
| JP2023515665A5 true JP2023515665A5 (https=) | 2024-03-05 |
Family
ID=77613738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552541A Pending JP2023515665A (ja) | 2020-03-06 | 2021-02-23 | 神経伝達物質トランスポーターの阻害剤の有効性を評価するための組成物及び方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12612661B2 (https=) |
| EP (1) | EP4106872A4 (https=) |
| JP (1) | JP2023515665A (https=) |
| KR (1) | KR20230005816A (https=) |
| CN (1) | CN115515680A (https=) |
| AR (1) | AR121515A1 (https=) |
| AU (1) | AU2021231683A1 (https=) |
| BR (1) | BR112022017770A2 (https=) |
| CA (1) | CA3174572A1 (https=) |
| IL (1) | IL296168A (https=) |
| MX (1) | MX2022010816A (https=) |
| TW (1) | TW202146660A (https=) |
| WO (1) | WO2021178166A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT202000019303A1 (it) * | 2020-08-05 | 2022-02-05 | Univ Degli Studi Di Brescia | Analoghi strutturali del metilfenidato come agenti disease-modifying della malattia di parkinson |
| CN114848835B (zh) * | 2022-03-22 | 2023-08-25 | 暨南大学 | 塞来昔布的聚乙二醇修饰及连接叶酸基团的靶向药物分子及制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6945457B1 (en) * | 1996-05-10 | 2005-09-20 | Transaction Holdings Ltd. L.L.C. | Automated transaction machine |
| JP4198582B2 (ja) * | 2003-12-02 | 2008-12-17 | 独立行政法人科学技術振興機構 | タンタルオキシナイトライド酸素還元電極触媒 |
| WO2007128884A1 (en) * | 2006-05-09 | 2007-11-15 | Oy Jurilab Ltd | Novel genes and markers in type 2 diabetes and obesity |
| US20080299125A1 (en) | 2006-06-05 | 2008-12-04 | Perlegen Sciences, Inc. | Genetic basis of treatment response in depression patients |
| WO2008065544A2 (en) | 2006-09-11 | 2008-06-05 | Mcgill University | Genetic predictors of risk for type 2 diabetes mellitus |
| EP2243834A1 (en) | 2007-03-05 | 2010-10-27 | Cancer Care Ontario | Assessment of risk for colorectal cancer |
| US20170029892A1 (en) | 2009-05-29 | 2017-02-02 | Jay L. Lombard | Methods and compositions for the treatment of post-traumatic stress disorder |
| US8355927B2 (en) * | 2010-11-05 | 2013-01-15 | Genomind, Llc | Neuropsychiatric test reports |
| EP2707498B1 (en) | 2011-01-31 | 2018-01-17 | Denovo Biomarkers Inc. | Method for discovering pharmacogenomic biomarkers |
| WO2012156515A1 (en) * | 2011-05-18 | 2012-11-22 | Rheinische Friedrich-Wilhelms-Universität Bonn | Molecular analysis of acute myeloid leukemia |
| CA2838207A1 (en) | 2011-06-08 | 2012-12-13 | Denovo Biopharma (Hangzhou) Ltd. Co. | Methods and compositions of predicting activity of retinoid x receptor modulator |
| US20140274764A1 (en) | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
| US20170253928A1 (en) | 2013-03-15 | 2017-09-07 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
| TR201907106T4 (tr) | 2014-03-14 | 2019-06-21 | Caredx Inc | Bir transplant alıcısında immünosüpresif terapileri izleme yöntemleri. |
-
2021
- 2021-02-23 CA CA3174572A patent/CA3174572A1/en active Pending
- 2021-02-23 KR KR1020227034374A patent/KR20230005816A/ko active Pending
- 2021-02-23 EP EP21764344.4A patent/EP4106872A4/en active Pending
- 2021-02-23 BR BR112022017770A patent/BR112022017770A2/pt unknown
- 2021-02-23 AU AU2021231683A patent/AU2021231683A1/en active Pending
- 2021-02-23 JP JP2022552541A patent/JP2023515665A/ja active Pending
- 2021-02-23 WO PCT/US2021/019265 patent/WO2021178166A1/en not_active Ceased
- 2021-02-23 IL IL296168A patent/IL296168A/en unknown
- 2021-02-23 US US17/905,511 patent/US12612661B2/en active Active
- 2021-02-23 MX MX2022010816A patent/MX2022010816A/es unknown
- 2021-02-23 CN CN202180031602.1A patent/CN115515680A/zh active Pending
- 2021-03-05 AR ARP210100576A patent/AR121515A1/es unknown
- 2021-03-05 TW TW110107927A patent/TW202146660A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Dickel et al. | Association studies of serotonin system candidate genes in early-onset obsessive-compulsive disorder | |
| Rahman | Polymerase chain reaction (PCR): a short review | |
| US20210054457A1 (en) | Autism associated genetic markers | |
| RU2018122965A (ru) | Улучшенный способ и набор для определения тяжести и прогрессирования периодонтального заболевания | |
| US20160376656A1 (en) | Single Nucleotide Polymorphism in HLA-B*15:02 and Use Thereof | |
| Yang et al. | The source of SYBR green master mix determines outcome of nucleic acid amplification reactions | |
| JP2023515665A5 (https=) | ||
| KR102158716B1 (ko) | Arhgap32 유전자의 단일염기다형성을 포함하는 뇌동맥류 진단용 snp 마커 | |
| EP2721171A1 (en) | Discrimination of blood type variants | |
| JP2013074888A (ja) | ＩＬ２８Ｂ（ｒｓ８０９９９１７）とＩＴＰＡ（ｒｓ１１２７３５４）の変異を検出する方法 | |
| Abdollahi et al. | Homogeneous assay of rs4343, an ACE I/D proxy, and an analysis in the British Women’s Heart and Health Study (BWHHS) | |
| Sjöroos et al. | Time‐resolved fluorometry based sandwich hybridisation assay for HLA‐DQA1 typing | |
| AU2011315926B2 (en) | Quantitative multiplexed identification of nucleic acid targets | |
| CN104293968B (zh) | 一组用于检测非综合征性唇腭裂遗传易感性的多态性位点及检测试剂盒 | |
| JP2010508029A (ja) | 抗うつ薬による治療時に有害事象を発現する危険性のある患者の識別方法 | |
| CN104862382A (zh) | 检测酒精代谢基因的方法及套组 | |
| JP2010508029A5 (https=) | ||
| Papanikos et al. | Lateral flow dipstick test for genotyping of 15 beta-globin gene (HBB) mutations with naked-eye detection | |
| Sebastian et al. | Integrated amplification microarray system in a lateral flow cell for warfarin genotyping from saliva | |
| EP2471949A1 (en) | Method for the identification by molecular techniques of genetic variants that encode no D antigen (D-) and altered C antigen (C+W) | |
| KR102268059B1 (ko) | 운동 민감도 예측용 조성물, 키트, 및 이를 이용한 방법 | |
| KR102879756B1 (ko) | 이상지질혈증 예측 또는 진단용 snp 마커 및 이의 용도 | |
| RU2675324C1 (ru) | Способ определения в гене галактозо-1-фосфатуридилтрансферазы человека мутации q188r, rs75391579 | |
| KR102511596B1 (ko) | 단일염기다형성을 이용한 안지오텐신 전환효소억제제 이상반응 진단용 조성물 및 이를 이용한 방법 | |
| JP2012000081A (ja) | Ｓｎｐによる肥満化のリスクの予測 |